Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

Status unconfirmed · Phase 1

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Diagnostic procedures, such as radionuclide imaging using bispecific antibody, may help find colorectal cancer cells and learn the extent of disease. PURPOSE: This phase I trial is studying how well a bispecific antibody works in finding tumor cells in patients with colorectal cancer.

Key facts

Study ID

NCT00895323

Run by

Garden State Cancer Center at the Center for Molecular Medicine and Immunology

People needed

9

Starts

2008-11-01

Last updated by the study team

2013-09-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.